| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.38B | +3.9% | +1.0% |
| Cost of Revenue | $1.17B | -0.4% | +3.3% |
| Gross Profit | $212.0M | — | -10.2% |
| R&D Expense | $26.0M | — | -3.7% |
| SG&A Expense | $147.0M | — | +19.5% |
| Interest Expense | $69.0M | — | +4.5% |
| Pre-tax Income | -$22.0M | +67.2% | — |
| Income Tax | $7.0M | — | +75.0% |
| Net Income | -$29.0M | +38.3% | -625.0% |
| EPS (Basic) | -$0.19 | +38.7% | -533.3% |
| EPS (Diluted) | -$0.19 | +38.7% | -533.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $563.0M | -16.0% | +21.3% |
| Accounts Receivable | $645.0M | +14.8% | -8.4% |
| Inventory | $1.54B | -2.1% | -0.9% |
| Current Assets | $2.93B | -2.4% | -0.2% |
| Total Assets | $7.27B | -1.6% | -1.7% |
| Current Liabilities | $1.61B | -4.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$44.0M | — | +60.7% |
| Capital Expenditures | $49.0M | — | -41.7% |
| Investing Cash Flow | -$44.0M | — | +48.8% |
| Financing Cash Flow | -$19.0M | — | +66.7% |
| Free Cash Flow | -$93.0M | — | +52.6% |
| -3.8% |
| Long-term Debt | $4.10B | +0.0% | +0.9% |
| Total Liabilities | $7.05B | -1.1% | +3.5% |
| Stockholders' Equity | $215.0M | -14.0% | -62.9% |